Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery

International Journal of Pharmaceutics

Volumn 372, Issue 1-2, 2009, Pages 191-198

  Lv, Qingzhi ^a   Yu, Aihua ^a   Xi, Yanwei ^a   Li, Houli ^a   Song, Zhimei ^a,b   Cui, Jing ^c   Cao, Fengliang ^a   Zhai, Guangxi ^a  

^a SHANDONG UNIVERSITY   (China)

^b UNIVERSITY OF JINAN   (China)

^c SHANDONG UNIVERSITY   (China)

Author keywords

DSC; HSV; Penciclovir; Skin permeation; Skin targeting; Solid lipid nanoparticles

Indexed keywords

PENCICLOVIR; SOLID LIPID NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG PENETRATION; DRUG UPTAKE; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN PENETRATION; STRATUM CORNEUM; TOPICAL DRUG ADMINISTRATION; ZETA POTENTIAL;

ACYCLOVIR; ADMINISTRATION, TOPICAL; ANIMALS; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; MALE; NANOPARTICLES; PARTICLE SIZE; RATS; RATS, WISTAR; SKIN ABSORPTION;

EID: 64149094878     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.01.014     Document Type: Article

References (50)

1. Ahmed A., Barry B.W., Williams A.C., and Davis A.F. Penciclovir solubility in Eudragit films: a comparison of X-ray, thermal, microscopic and release rate techniques. J. Pharm. Biomed. Anal. 34 (2004) 945-956
2. Andrei G., Clercq E.D., and Snoeck R. In vitro selection of drug-resistant varicella zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir. Antiviral Res. 61 (2004) 181-187
3. Bianca B., Quintela M.A.L., Charro M.A.D., Fadda M.B., Fadda A.M., and Mendez J.B. Microemulsions for topical delivery of 8-methoxsalen. J. Control. Release 69 (2000) 209-218
4. Bouwstra J.A., Gooris G.S., Bras W., and Downing D.T. Lipid organization in pig stratum corneum. J. Lipid Res. 36 (1995) 685-695
5. Cevc G. Lipid vesicles and other colloids as drug carriers on the skin. Adv. Drug Deliv. Rev. 56 (2004) 675-711
6. Chen H., Chang X., Du D., Liu W., Liu J., Weng T., Yang Y., Xu H., and Yang X. Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J. Control. Release 110 (2006) 296-306
7. Christophers E., and Kligman A.M. Preparation of isolated sheets of human stratum corneum. Arch. Dermatol. 88 (1963) 702-705
8. Corrigan D.O., Healy A.M., and Corrigan O.I. The effect of spray drying solutions of bendroflumethiazide/polyethylene glycol on the physicochemical properties of the resultant materials. Int. J. Pharm. 262 (2003) 125-137
9. El Maghraby G.M., Barry B.W., and Williams A.C. Liposomes and skin: from drug delivery to model membranes. Eur. J. Pharm. Sci. 34 (2008) 203-222
10. Fang J.Y., Fang C.L., Liu C.H., and Su Y.H. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur. J. Pharm. Biopharm. 70 (2008) 633-640
11. Gao L., Zhang D., Chen M., Duan C., Dai W., Jia L., and Zhao W. Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions. Int. J. Pharm. 355 (2008) 321-327
12. García-Fuentes M., Torres D., and Alonso M.J. Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules. Colloid Surf. B 27 (2002) 159-168
13. Hassonville S.H., Chiap P., Liégeois J., Evrard B., Delattre L., Crommen J., Piel G., and Hubert P. Development and validation of a high-performance liquid chromatographic method for the determination of cyproterone acetate in human skin. J. Pharm. Biomed. Anal. 36 (2004) 133-143
14. Heiati H., Phillips N.C., and Tawashi R. Evidence for phospholipid bilayer formation in solid lipid nanoparticles formulated with phospholipid and triglyceride. Pharm. Res. 13 (1996) 1406-1410
15. Hou D.Z., Xie C.S., Huang K.J., and Zhu C.H. The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials 24 (2003) 1781-1785
16. 10 nanoparticles engineered from microemulsion precursors. AAPS Pharm. Sci. Technol. 4 (2003) 1-12
17. Jenning V., Gysler A., Schäfer-Korting M., and Gohla S. Vitamin A-loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur. J. Pharm. Biopharm. 49 (2000) 211-218
18. Jenning V., Thünemann A.F., and Gohla S.H. Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int. J. Pharm. 199 (2000) 167-177
19. Kuntsche J., Bunjes H., Fahr A., Pappinen S., Ronkko S., Suhonen M., and Urtti A. Interaction of lipid nanoparticles with human epidermis and an organotypic cell culture model. Int. J. Pharm. 354 (2008) 180-195
20. Liu M., Dong J., Yang Y., Yang X., and Xu H. Characterization and release of triptolide-loaded poly (d, l-lactic acid) nanoparticles. Eur. Polym. J. 41 (2005) 375-382
21. Liu J., Gong T., Wang C., Zhong Z., and Zhang Z. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization. Int. J. Pharm. 340 (2007) 153-162
22. Liu J., Hu W., Chen H., Ni Q., Xu H., and Yang X. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int. J. Pharm. 328 (2007) 191-195
23. Luo Y.F., Chen D.W., Ren L.X., Zhao X.L., and Qin J. Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability. J. Control. Release 114 (2006) 53-59
24. Maia C.S., Mehnert W., and Schäfer-Korting M. Solid lipid nanoparticles as drug carriers for topical glucocorticoids. Int. J. Pharm. 196 (2000) 165-167
25. Maia C.S., Mehnert W., Schaller M., Korting H.C., Gysler A., Haberland A., and Schäfer-Korting M. Drug targeting by solid lipid nanoparticles for dermal use. J. Drug Target. 10 (2002) 489-495
26. Mehnert W., and Mäder K. Solid lipid nanoparticles-production, characterization and applications. Adv. Drug Deliv. Rev. 47 (2001) 165-196
27. Mei Z., Chen H., Wang T., Yang Y., and Yang X. Solid lipid nanoparticle and microemulsion for topical delivery of triptolide. Eur. J. Pharm. Biopharm. 56 (2003) 189-196
28. Morissettea S.L., Almarsson O., Peterson M.L., Remenar J.F., Read M.J., Lemmo A.V., Ellis S., Cima M.J., and Colin R.G. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids. Adv. Drug Deliv. Rev. 56 (2004) 275-300
29. Mühlen A., and Mehnert W. Drug release and release mechanism of prednisolone loaded solid lipid nanoparticles. Pharmazie 53 (1998) 552-555
30. Müller R.H., Mäder K., and Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art. Eur. J. Pharm. Biopharm. 50 (2000) 161-177
31. Puglia C., Bonina F., Trapani G., Franco M., and Ricci M. Evaluation of in vitro percutaneous absorption of lorazepam and clonazepam from hydro-alcoholic gel formulations. Int. J. Pharm. 228 (2001) 79-87
32. Puglia C., Blasi P., Rizza L., Schoubben A., Bonina F., Rossi C., and Ricci M. Lipid nanoparticles for prolonged topical delivery: an in vitro and in vivo investigation. Int. J. Pharm. 357 (2008) 295-304
33. Schäfer-Korting M., Mehnert W., and Korting H. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv. Drug Deliv. Rev. 59 (2007) 427-443
34. Schmid-Wendtner M.H., and Korting H.C. Penciclovir cream-improved topical treatment for herpes simplex infections. Skin Pharmacol. Physiol. 17 (2004) 214-218
35. Shah K.A., Date A.A., Joshi M.D., and Patravale V.B. Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. Int. J. Pharm. 345 (2007) 163-171
36. Singh S., Bhardwaj P., Singh V., Aggarwal S., and Mandal U.K. Synthesis of nanocrystalline calcium phosphate in microemulsion-effect of nature of surfactants. J. Colloid Interface Sci. 319 (2008) 322-329
37. Sivaramakrishnan R., Nakamura C., Mehnert W., Korting H.C., Kramer K.D., and Schäfer-Korting M. Glucocorticoid entrapment into lipid carriers-characterization by parelectric spectroscopy and influence on dermal uptake. J. Control. Release 97 (2004) 493-502
38. Smith R.L., Morroni J., and Wilcox C.L. Lack of effect of treatment with penciclovir or acyclovir on the establishment of latent HSV-1 in primary sensory neurons in culture. Antiviral Res. 52 (2001) 19-24
39. Souto E.B., Wissing S.A., Barbosa C.M., and Müller R.H. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int. J. Pharm. 278 (2004) 71-77
40. Sun W., Zhang N., Li A., Zou W., and Xu W. Preparation and evaluation of N3-O-toluyl-fluorouracil-loaded liposomes. Int. J. Pharm. 353 (2008) 243-250
41. 10-development, physicochemical characterization and in vitro release studies. Eur. J. Pharm. Biopharm. 67 (2007) 141-148
42. Tiyaboonchai W., Tungpradit W., and Plianbangchang P. Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. Int. J. Pharm. 337 (2007) 299-306
43. Venkateswarlu V., and Manjunath K. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J. Control. Release 95 (2004) 627-638
44. Westesen K., and Bunjes H. Do nanoparticles prepared from lipids solid at room temperature always possess a solid lipid matrix?. Int. J. Pharm. 115 (1995) 129-131
45. Wissing S.A., and Müller R.H. Solid lipid nanoparticles (SLN)-a novel carrier for UV blockers. Pharmazie 56 (2001) 783-786
46. Wissing S.A., and Müller R.H. Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration. J. Control. Release 81 (2002) 225-233
47. Wissing S.A., and Müller R.H. The influence of solid lipid nanoparticles on skin hydration and viscoelasticity-in vivo study. Eur. J. Pharm. Biopharm. 56 (2003) 67-72
48. Yokomizo Y., and Sagitani H. The effects of phospholipids on the percutaneous penetration of indomethacin through the dorsal skin of guinea pig in vitro. 2. The effects of the hydrophobic group in phospholipids and a comparison with general enhancers. J. Control. Release 42 (1996) 37-46
49. Zellmer S., Pfeil W., and Lasch J. Interaction of phosphatidylcholine liposomes with the human stratum corneum. Biochim. Biophys. Acta 1237 (1995) 176-182
50. Zhu W.W., Yu A.H., Wang W.H., Dong R.Q., Wu J., and Zhai G.X. Formulation design of microemulsion for dermal delivery of penciclovir. Int. J. Pharm. 360 (2008) 184-190